Back
Rapt Therapeutics, Inc. Stock Predictions
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
44
RAPT
Rapt Therapeutics, Inc.
Last Price:
$34.00
Seasonality Move:
-10.23%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiRapt Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Rapt Therapeutics, Inc. has on average historically risen by 30.1% based on the past 6 years of stock performance.
-
Rapt Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Rapt Therapeutics, Inc. Stock Undervalued?The current Rapt Therapeutics, Inc. [RAPT] share price is $34.03. The Score for RAPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
RAPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Rapt Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Rapt Therapeutics, Inc. has on average historically risen by 30.1% based on the past 6 years of stock performance.
Rapt Therapeutics, Inc. Stock Rating
Sell
44
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. overpriced?
-
Rapt Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Rapt Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
rapt.com
52-Week Data
52-Week High:
42.39
52-Week Low:
5.67
Prediction Charts
Market Cap:
562.8M
Price in USD:
34.03
Volume:
338.3K
Beta:
0.32
Technical Analysis
SMA50:
30.48
SMA100:
22.97
SMA200:
15.73
52-Wk Change:
382.67%
Stock Predictions
-
Is Rapt Therapeutics, Inc. stock public?Yes, Rapt Therapeutics, Inc. is a publicly traded company.
-
What is the Rapt Therapeutics, Inc. stock quote today?The Rapt Therapeutics, Inc. stock price is 34.03 USD today.
-
How to buy Rapt Therapeutics, Inc. stock online?You can buy Rapt Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-26 | 30.15 | 33.26 | 34.46 | 29.76 |
| Nov-28 | 33.26 | 33.80 | 35.10 | 32.17 |
| Dec-1 | 33.56 | 31.51 | 33.56 | 31.44 |
| Dec-2 | 31.52 | 32.33 | 32.40 | 30.00 |
| Dec-3 | 32.25 | 32.09 | 32.50 | 31.24 |
| Dec-4 | 32.08 | 34.47 | 34.73 | 31.72 |
| Dec-5 | 34.47 | 34.47 | 35.72 | 33.90 |
| Dec-8 | 34.80 | 34.94 | 35.73 | 34.01 |
| Dec-9 | 34.56 | 35.32 | 35.64 | 34.31 |
| Dec-10 | 35.12 | 36.62 | 37.29 | 34.25 |
| Dec-11 | 36.31 | 35.28 | 37.50 | 35.14 |
| Dec-12 | 35.35 | 36.80 | 38.45 | 35.27 |
| Dec-15 | 36.83 | 33.22 | 37.39 | 32.98 |
| Dec-16 | 32.54 | 34.03 | 34.59 | 31.73 |
Rapt Therapeutics, Inc. Earnings
Rapt Therapeutics, Inc. Earnings Report: Per Share Rapt Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Rapt Therapeutics, Inc. Forecast Revenue Growth
Rapt Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Rapt Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.75 per share, and a decrease next year of $0.91 per share.
* Rapt Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.